{"organizations": [], "uuid": "f1c999baae9a2aeb51f968c5d098e13d65edff45", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-valirx-announces-us-patent-grant-f/brief-valirx-announces-us-patent-grant-for-therapeutic-compound-val201-idUSFWN1R201C", "country": "US", "domain_rank": 408, "title": "BRIEF-Valirx Announces US Patent Grant for Therapeutic Compound, VAL201", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-20T09:20:00.000+02:00", "replies_count": 0, "uuid": "f1c999baae9a2aeb51f968c5d098e13d65edff45"}, "author": "", "url": "https://www.reuters.com/article/brief-valirx-announces-us-patent-grant-f/brief-valirx-announces-us-patent-grant-for-therapeutic-compound-val201-idUSFWN1R201C", "ord_in_thread": 0, "title": "BRIEF-Valirx Announces US Patent Grant for Therapeutic Compound, VAL201", "locations": [], "entities": {"persons": [{"name": "valirx", "sentiment": "none"}], "locations": [{"name": "us", "sentiment": "none"}], "organizations": [{"name": "us patent grant for therapeutic compound", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "valirx plc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 20, 2018 / 7:24 AM / Updated 44 minutes ago BRIEF-Valirx Announces US Patent Grant for Therapeutic Compound, VAL201 Reuters Staff 1 Min Read March 20 (Reuters) - Valirx Plc: * USA PATENT AND TRADEMARK OFFICE GRANTED US PATENT APPLICATION COVERING VALIRX’S LEAD THERAPEUTIC COMPOUND​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-03-20T09:20:00.000+02:00", "crawled": "2018-03-20T10:06:06.001+02:00", "highlightTitle": ""}